Ypsomed Holding AGXSWX:YPSN +1.91%91 PB Ratio is 6.20 as of Jun. 25, 2026, which is 9% above its 10-year median of 5.69. GuruFocus rates XSWX:YPSN with a GF Score™ of 91/100 and a GF Value™ of CHF397.48 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Ypsomed Holding AG ranks worse than 84.14% on this metric.
The historical rank and industry rank for Ypsomed Holding AG's PB Ratio or its related term are showing as below:
XSWX:YPSN'
s PB Ratio Range Over the Past 10 Years
Min: 3.69 Med: 5.69 Max: 9.44
Current: 6.21
During the past 13 years, Ypsomed Holding AG's highest PB Ratio was 9.44. The lowest was 3.69. And the median was 5.69.
XSWX:YPSN's PB Ratio is ranked worse than 84.14% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs XSWX:YPSN: 6.21
During the past 12 months, Ypsomed Holding AG's average Book Value Per Share Growth Rate was 14.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 11.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 13.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Ypsomed Holding AG was 17.20% per year. The lowest was -90.10% per year. And the median was 5.15% per year.
Back to Basics: PB Ratio
Ypsomed Holding AG (XSWX:YPSN) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Ypsomed Holding AG PB Ratio Related Terms
Ypsomed Holding AG PB Ratio Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Ypsomed Holding AG (XSWX:YPSN) has a PB Ratio of 6.20 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Ypsomed Holding AG and its competitors. This is near median its historical median of 5.69. Over the past decade, Ypsomed Holding AG's PB Ratio has ranged from 3.69 to 9.44. According to the industry distribution chart, Ypsomed Holding AG ranks #663 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 84.1%.
Is Ypsomed Holding AG's PB Ratio too high?
Ypsomed Holding AG's current PB Ratio of 6.20 is near median its 10-year median of 5.69. Over the past 10 years, this metric has ranged from a low of 3.69 to a high of 9.44. The Medical Devices & Instruments industry median PB Ratio is 2.05. Ypsomed Holding AG's value of 6.20 is 203.2% above this industry median. Based on the distribution chart, Ypsomed Holding AG ranks #663 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ypsomed Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #663 out of 788 companies for PB Ratio. This places Ypsomed Holding AG in the lower half of its industry. The industry median PB Ratio is 2.05. Ypsomed Holding AG's value of 6.20 is 203.2% above this benchmark. Historically, Ypsomed Holding AG's own PB Ratio has ranged from 3.69 to 9.44 over the past decade. While the company's 10-year median is 5.69 vs. the industry median of 2.05, Ypsomed Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current PB Ratio of 6.20 is 203.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current PB Ratio is 6.20, which is near median its own 10-year median of 5.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF397.48, compared to a current price of CHF353.00 — trading 11.2% below its estimated fair value. The current PB Ratio is 6.20, which is near median its 10-year median of 5.69 and 203.2% above the Medical Devices & Instruments industry median of 2.05. Ypsomed Holding AG's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current PB Ratio is 6.20 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued.
The current stock price of CHF353.00 is trading 11.2% below its estimated GF Value™ of CHF397.48.
GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:YPSN:
PB Ratio: 6.20 (near median its 10-year median of 5.69)
GF Value™: CHF397.48 vs. price of CHF353.00 (11.2% below fair value)
Industry Position: 203.2% above the Medical Devices & Instruments median (#663 of 788)
No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
91GF Score
Get the complete analysis for XSWX:YPSN
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:YPSN has been successfully added to your 
